Ignite Creation Date:
2024-06-16 @ 11:52 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06456242
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-13
First Post:
2024-06-04
Brief Title:
Contingency Management to Promote Smoking Cessation
Sponsor:
University of Kansas Medical Center
Organization:
University of Kansas Medical Center
Study Overview
Official Title:
Using Contingency Management to Promote Adherence to Smoking Cessation Treatment
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Many hospitals and outpatient clinics often refer people who smoke to quitlines and provide prescriptions for smoking cessation medications but patients rarely fully engage in counseling or use their cessation medications This is a single-arm open-label pilot study to provide feasibility metrics for a text-based contingency management CM intervention to increase engagement in smoking cessation treatment All participants N20 will be referred to a state quitline and will receive a prescription for medication plus 12 weeks of a text-based CM intervention to increase engagement in quitline calls and varenicline utilization The engagement of participants in quitline counseling will be tracked for 6 weeks and medication utilization for 12 weeks post-enrollment The investigators will use mixed-methods to collect implementation and acceptability data to inform changes to the text-based contingency management CM intervention
Detailed Description:
Novel approaches are needed to engage people who smoke in treatment in a way that increases their odds of quitting Contingency management CM interventions provide financial incentives to participants contingent on objective evidence of behavior change and are effective in enhancing medication adherence and treatment engagement for numerous health conditions including tobacco dependence treatment Critical gaps however remain in our knowledge regarding how best to deploy CM
The goal of this study is to evaluate the acceptability and feasibility of combined CM for engaging patients in smoking cessation treatment Participants N20 will receive CounsCM for engaging in five quitline calls and MedCM for utilizing varenicline over twelve weeks CM payments will be automated and dispensed on a daily basis using a reloadable debit card The investigators will use surveys and structured interviews to understand strengths weaknesses and areas for improvement
The goal of this study is to evaluate the acceptability and feasibility of combined CM for engaging patients in smoking cessation treatment Participants N20 will receive CounsCM for engaging in five quitline calls and MedCM for utilizing varenicline over twelve weeks CM payments will be automated and dispensed on a daily basis using a reloadable debit card The investigators will use surveys and structured interviews to understand strengths weaknesses and areas for improvement
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None